{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:06:34Z","timestamp":1747166794255,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","award":["319337"],"award-info":[{"award-number":["319337"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10549-020-05664-9","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T11:02:58Z","timestamp":1588935778000},"page":"159-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The impact of ductal carcinoma in situ on health services utilization"],"prefix":"10.1007","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3595-1493","authenticated-orcid":false,"given":"Lawrence","family":"Paszat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinku","family":"Sutradhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Rakovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"issue":"6","key":"5664_CR1","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/jnci\/djr027","volume":"103","author":"IL Wapnir","year":"2011","unstructured":"Wapnir IL, Dignam JJ, Fisher B et al (2011 ) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103(6):478\u2013488","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"5664_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","volume":"12","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, Sestak I, Pinder SE et al (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial. Lancet Oncol. 12(1):21\u201329","journal-title":"Lancet Oncol."},{"issue":"32","key":"5664_CR3","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","volume":"31","author":"M Donker","year":"2013","unstructured":"Donker M, Liti\u00e8re S, Werutsky G et al (2013 ) Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol 31(32):4054\u20134059","journal-title":"J Clin Oncol"},{"issue":"32","key":"5664_CR4","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","volume":"32","author":"F W\u00e4rnberg","year":"2014","unstructured":"W\u00e4rnberg F, Garmo H, Emdin S et al (2014 ) Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial. J Clin Oncol 32(32):3613\u20133618","journal-title":"J Clin Oncol"},{"issue":"7","key":"5664_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","volume":"33","author":"B McCormick","year":"2015","unstructured":"McCormick B, Winter K, Hudis C et al (2015 ) RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol 33(7):709\u2013715","journal-title":"J Clin Oncol"},{"key":"5664_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000563.pub7","author":"A Goodwin","year":"2013","unstructured":"Goodwin A, Parker S, Ghersi D, Wilcken N (2013) Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD000563.pub7","journal-title":"Cochrane Database Syst Rev"},{"issue":"9935","key":"5664_CR7","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"P McGale","year":"2014","unstructured":"EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C et al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383(9935):2127\u20132135","journal-title":"Lancet"},{"issue":"16","key":"5664_CR8","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/jnci\/djh248","volume":"96","author":"PC G\u00f8tzsche","year":"2004","unstructured":"G\u00f8tzsche PC (2004 ) Re: Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 96(16):1257","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"5664_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/bcr1397","volume":"8","author":"JL Jones","year":"2006","unstructured":"Jones JL (2006) Overdiagnosis and overtreatment of breast cancer: progression of ductal carcinoma in situ: the pathological perspective. Breast Cancer Res 8(2):204","journal-title":"Breast Cancer Res"},{"issue":"6","key":"5664_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/bcr1346","volume":"7","author":"AS Kumar","year":"2005","unstructured":"Kumar AS, Bhatia V, Henderson IC (2005) Overdiagnosis and overtreatment of breast cancer: rates of ductal carcinoma in situ: a US perspective. Breast Cancer Res 7(6):271\u2013275","journal-title":"Breast Cancer Res"},{"issue":"5","key":"5664_CR11","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ejso.2017.02.003","volume":"43","author":"A Hosseini","year":"2017","unstructured":"Hosseini A, Khoury AL, Esserman LJ (2017 ) Precision surgery and avoiding over-treatment. Eur J Surg Oncol 43(5):938\u2013943","journal-title":"Eur J Surg Oncol"},{"issue":"16","key":"5664_CR12","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","volume":"51","author":"A Francis","year":"2015","unstructured":"Francis A, Thomas J, Fallowfield L et al (2015 ) Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer 51(16):2296\u20132303. https:\/\/doi.org\/10.1016\/j.ejca.2015.07.017","journal-title":"Eur J Cancer"},{"issue":"12","key":"5664_CR13","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","volume":"51","author":"LE Elshof","year":"2015","unstructured":"Elshof LE, Tryfonidis K, Slaets L et al (2015) Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study. Eur J Cancer 51(12):1497\u20131510. https:\/\/doi.org\/10.1016\/j.ejca.2015.05.008","journal-title":"Eur J Cancer"},{"issue":"3","key":"5664_CR14","doi-asserted-by":"publisher","first-page":"e026797","DOI":"10.1136\/bmjopen-2018-026797","volume":"9","author":"ES Hwang","year":"2019","unstructured":"Hwang ES, Hyslop T, Lynch T et al (2019 ) The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open 9(3):e026797. https:\/\/doi.org\/10.1136\/bmjopen-2018-026797","journal-title":"BMJ Open"},{"issue":"10","key":"5664_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/jnci\/djt067","volume":"105","author":"LJ Solin","year":"2013","unstructured":"Solin LJ, Gray R, Baehner FL et al (2013 ) A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst 105(10):701\u2013710","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"5664_CR16","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-18-0842","volume":"24","author":"T Bremer","year":"2018","unstructured":"Bremer T, Whitworth PW, Patel R et al (2018) A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk. Clin Cancer Res 24(23):5895\u20135901. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0842PMID:30054280","journal-title":"Clin Cancer Res"},{"issue":"2","key":"5664_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10549-015-3464-6","volume":"152","author":"E Rakovitch","year":"2015","unstructured":"Rakovitch E, Nofech-Mozes S, Hanna W et al (2015 ) A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone. Breast Cancer Res Treat 152(2):389\u2013398","journal-title":"Breast Cancer Res Treat"},{"key":"5664_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw256","author":"E Rakovitch","year":"2017","unstructured":"Rakovitch E, Nofech-Mozes S, Hanna W et al (2017) Multigene expression assay and benefit of radiotherapy after breast conservation in ductal carcinoma in situ. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djw256","journal-title":"J Natl Cancer Inst."},{"issue":"3","key":"5664_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1023\/A:1021853302033","volume":"77","author":"E Rakovitch","year":"2003","unstructured":"Rakovitch E, Franssen E, Kim J, Ackerman I, Pignol JP, Paszat L, Pritchard KI, Ho C, Redelmeier DA (2003 ) A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 77(3):285\u2013293","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5664_CR20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ejca.2006.10.010","volume":"43","author":"YR van Gestel","year":"2007","unstructured":"van Gestel YR, Voogd AC, Vingerhoets AJ, Mols F, Nieuwenhuijzen GA, van Driel OJ, van Berlo CL, van de Poll-Franse LV (2007 ) A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. Eur J Cancer 43(3):549\u2013556","journal-title":"Eur J Cancer"},{"issue":"3","key":"5664_CR21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s10549-009-0477-z","volume":"120","author":"S Lauzier","year":"2010","unstructured":"Lauzier S, Maunsell E, Levesque P, Mondor M, Robert J, Robidoux A, Provencher L (2010 ) Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer. Breast Cancer Res Treat 120(3):685\u2013691","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5664_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10549-011-1551-x","volume":"130","author":"Y Liu","year":"2011","unstructured":"Liu Y, P\u00e9rez M, Schootman M, Aft RL, Gillanders WE, Jeffe DB (2011 ) Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 130(1):165\u2013173","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5664_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10549-017-4495-y","volume":"167","author":"ML Gregorowitsch","year":"2018","unstructured":"Gregorowitsch ML, van den Bongard HJGD, Young-Afat DA, Pignol JP, van Gils CH, May AM, Verkooijen HM (2018 ) Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients. Breast Cancer Res Treat 167(1):205\u2013213","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"5664_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/jnci\/djn010","volume":"100","author":"A Partridge","year":"2008","unstructured":"Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E (2008 ) Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst 100(4):243\u2013251. https:\/\/doi.org\/10.1093\/jnci\/djn010","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"5664_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.pmn.2017.03.004","volume":"18","author":"BG Mertz","year":"2017","unstructured":"Mertz BG, Duriaud HM, Kroman N, Andersen KG (2017 ) Pain, Sensory Disturbances, and Psychological Distress among Danish Women Treated for Ductal Carcinoma In Situ: An Exploratory Study. Pain Manag Nurs 18(5):309\u2013317. https:\/\/doi.org\/10.1016\/j.pmn.2017.03.004","journal-title":"Pain Manag Nurs"},{"issue":"4","key":"5664_CR26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/ijc.30514","volume":"140","author":"H Yang","year":"2017","unstructured":"Yang H, Brand JS, Fang F, Chiesa F, Johansson AL, Hall P, Czene K (2017) Time-dependent risk of depression, anxiety, and stress-related disorders in patients with invasive and in situ breast cancer. Int J Cancer 140(4):841\u2013852","journal-title":"Int J Cancer"},{"key":"5664_CR27","doi-asserted-by":"publisher","first-page":"h440","DOI":"10.1136\/bmj.h440","volume":"350","author":"AD Hanchate","year":"2015","unstructured":"Hanchate AD, Kapoor A, Katz JN et al (2015) Massachusetts health reform and disparities in joint replacement use: difference in differences study. BMJ 350:h440","journal-title":"BMJ"},{"key":"5664_CR28","unstructured":"Introduction to econometrics, James H. Stock, Mark W. Watson. 2nd ed., Boston: Pearson Addison Wesley, 2007."},{"issue":"7","key":"5664_CR29","first-page":"697","volume":"9","author":"A Trentham-Dietz","year":"2000","unstructured":"Trentham-Dietz A, Newcomb PA, Storer BE, Remington PL (2000 ) Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 9(7):697\u2013703","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"5664_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1023\/A:1022147920262","volume":"78","author":"EB Claus","year":"2003","unstructured":"Claus EB, Stowe M, Carter D (2003) Family history of breast and ovarian cancer and the risk of breast carcinoma in situ. Breast Cancer Res Treat 78(1):7\u201315","journal-title":"Breast Cancer Res Treat"},{"key":"5664_CR31","doi-asserted-by":"publisher","first-page":"101648","DOI":"10.1016\/j.canep.2019.101648","volume":"64","author":"R Peila","year":"2020","unstructured":"Peila R, Arthur R, Rohan TE (2020 ) Risk factors for ductal carcinoma in situ of the breast in the UK Biobank cohort study. Cancer Epidemiol 64:101648. https:\/\/doi.org\/10.1016\/j.canep.2019.101648","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"5664_CR32","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/bcr1507","volume":"8","author":"JK Gill","year":"2006","unstructured":"Gill JK, Maskarinec G, Pagano I, Kolonel LN (2006) The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort. Breast Cancer Res 8(3):R30","journal-title":"Breast Cancer Res"},{"issue":"9","key":"5664_CR33","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10552-007-9035-3","volume":"18","author":"TA MacKenzie","year":"2007","unstructured":"MacKenzie TA, Titus-Ernstoff L, Vacek PM, Geller B, Weiss JE, Goodrich ME, Carney PA (2007 ) Breast density in relation to risk of ductal carcinoma in situ of the breast in women undergoing screening mammography. Cancer Causes Control 18(9):939\u2013945","journal-title":"Cancer Causes Control"},{"issue":"12","key":"5664_CR34","first-page":"961","volume":"5","author":"MP Longnecker","year":"1996","unstructured":"Longnecker MP, Bernstein L, Paganini-Hill A, Enger SM, Ross RK (1996 ) Risk factors for in situ breast cancer. Cancer Epidemiol Biomarkers Prev 5(12):961\u2013965","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"23","key":"5664_CR35","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1200\/JCO.2003.05.151","volume":"21","author":"K Kerlikowske","year":"2003","unstructured":"Kerlikowske K, Miglioretti DL, Ballard-Barbash R, Weaver DL, Buist DS, Barlow WE, Cutter G, Geller BM, Yankaskas B, Taplin SH, Carney PA (2003 ) Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol 21(23):4314\u20134321","journal-title":"J Clin Oncol"},{"issue":"41","key":"5664_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/jncimonographs\/lgq027","volume":"2010","author":"K Kerlikowske","year":"2010","unstructured":"Kerlikowske K (2010) Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010(41):139\u2013141. https:\/\/doi.org\/10.1093\/jncimonographs\/lgq027","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"5","key":"5664_CR37","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1158\/1055-9965.EPI-11-1115","volume":"21","author":"DS Buist","year":"2012","unstructured":"Buist DS, Walker R, Bowles EJ, Carney PA, Taplin SH, Onega T, Kerlikowske K, Clinton W, Miglioretti DL (2012 ) Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence. Cancer Epidemiol Biomarkers Prev 21(5):720\u2013727. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-1115","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"5664_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/jnci\/89.1.76","volume":"89","author":"K Kerlikowske","year":"1997","unstructured":"Kerlikowske K, Barclsay J, Grady D, Sickles EA, Ernster V (1997 ) Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst 89(1):76\u201382","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"5664_CR39","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1158\/1055-9965.EPI-08-0967","volume":"18","author":"LS Phillips","year":"2009","unstructured":"Phillips LS, Millikan RC, Schroeder JC, Barnholtz-Sloan JS, Levine BJ (2009 ) Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 18(5):1507\u20131514. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0967","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"5664_CR40","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1200\/JCO.2015.62.7281s","volume":"34","author":"V Hart","year":"2016","unstructured":"Hart V, Sprague BL, Lakoski SG, Hampton JM, Newcomb PA, Gangnon RE, Trentham-Dietz A (2016 ) Trends in Health-Related Quality of Life After a Diagnosis of Ductal Carcinoma In Situ. J Clin Oncol 34(12):1323\u20131329. https:\/\/doi.org\/10.1200\/JCO.2015.62.7281s","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05664-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-05664-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05664-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T01:10:08Z","timestamp":1620436208000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-05664-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["5664"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05664-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"assertion":[{"value":"30 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"E Rakovitch has received research grant funding from Genomic Health Inc. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the Sunnybrook Health Sciences Centre Research Ethics Board. It is an observational analysis, and no procedures or interventions were performed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This is a population-based retrospective analysis. All personal identifiers for each case in this population cohort were removed. This study was facilitated through ICES which is named as a prescribed entity in Sect.\u00a045 of PHIPA (Regulation 329\/04, Sect.\u00a018) which allows access and utilization of administrative data for research purposes with a waived requirement for consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}